[
    {
        "molecule_name": "2(S)-amino-6-boronohexanoic acid (ABH)",
        "protein_target_name": "ARG",
        "binding_metric": "KD",
        "value": "0.3",
        "unit": "mM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The boronic acids 2(S)-amino-6-boronohexanoic acid (ABH) and S-(2-boronoethyl)-L- cysteine (BEC) are potent inhibitors of both ARG isoforms at physiologic pH (with binding constant (KD) of approximately 0.3 mM), binding with much higher affinity than the natural substrate (L-arginine K<sub>m</sub> is 5 mM) (Ash et al., 2004; Christianson et al., 2005).\n* Human ARG1 was crystallized in association with both inhibitors and new insights into the catalytic mechanism have been gained (Di Costanzo et al., 2005), with L-arginine K<sub>m</sub> of 5 mM. \n* The boronic acid 2(S)-amino-6-boronohexanoic acid (ABH) has a binding constant (KD) of approximately 0.3 mM."
    },
    {
        "molecule_name": "S-(2-boronoethyl)-L-cysteine (BEC)",
        "protein_target_name": "ARG",
        "binding_metric": "KD",
        "value": "0.3",
        "unit": "mM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The boronic acids 2(S)-amino-6-boronohexanoic acid (ABH) and S-(2-boronoethyl)-L- cysteine (BEC) are potent inhibitors of both ARG isoforms at physiologic pH (with binding constant (KD) of approximately 0.3 mM), binding with much higher affinity than the natural substrate (L-arginine K<sub>m</sub> is 5 mM) (Ash et al., 2004; Christianson et al., 2005).\n* Human ARG1 was crystallized in association with both inhibitors and new insights into the catalytic mechanism have been gained (Di Costanzo et al., 2005), with L-arginine K<sub>m</sub> of 5 mM. \n* The boronic acid 2(S)-amino-6-boronohexanoic acid (ABH) has a binding constant (KD) of approximately 0.3 mM."
    },
    {
        "molecule_name": "L-arginine",
        "protein_target_name": "ARG",
        "binding_metric": "Km",
        "value": "5",
        "unit": "mM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The boronic acids 2(S)-amino-6-boronohexanoic acid (ABH) and S-(2-boronoethyl)-L- cysteine (BEC) are potent inhibitors of both ARG isoforms at physiologic pH (with binding constant (KD) of approximately 0.3 mM), binding with much higher affinity than the natural substrate (L-arginine K<sub>m</sub> is 5 mM) (Ash et al., 2004; Christianson et al., 2005).\n* Human ARG1 was crystallized in association with both inhibitors and new insights into the catalytic mechanism have been gained (Di Costanzo et al., 2005), with L-arginine K<sub>m</sub> of 5 mM. \n* The boronic acid 2(S)-amino-6-boronohexanoic acid (ABH) has a binding constant (KD) of approximately 0.3 mM."
    },
    {
        "molecule_name": "L-arginine",
        "protein_target_name": "ARG1",
        "binding_metric": "Km",
        "value": "5",
        "unit": "mM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The boronic acids 2(S)-amino-6-boronohexanoic acid (ABH) and S-(2-boronoethyl)-L- cysteine (BEC) are potent inhibitors of both ARG isoforms at physiologic pH (with binding constant (KD) of approximately 0.3 mM), binding with much higher affinity than the natural substrate (L-arginine K<sub>m</sub> is 5 mM) (Ash et al., 2004; Christianson et al., 2005).\n* Human ARG1 was crystallized in association with both inhibitors and new insights into the catalytic mechanism have been gained (Di Costanzo et al., 2005), with L-arginine K<sub>m</sub> of 5 mM. \n* The boronic acid 2(S)-amino-6-boronohexanoic acid (ABH) has a binding constant (KD) of approximately 0.3 mM."
    }
]